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Sterol regulatory element-binding proteins (SREBPs)
activate genes involved in the synthesis and traf-
ficking of cholesterol and other lipids and are critical
for maintaining lipid homeostasis. Aberrant SREBP
activity, however, can contribute to obesity, fatty liver
disease, and insulin resistance, hallmarks of meta-
bolic syndrome. Our studies identify a conserved
regulatory circuit in which SREBP-1 controls genes
in the one-carbon cycle, which produces the methyl
donor S-adenosylmethionine (SAMe). Methylation
is critical for the synthesis of phosphatidylcholine
(PC), a major membrane component, and we find
that blocking SAMe or PC synthesis in C. elegans,
mouse liver, and human cells causes elevated
SREBP-1-dependent transcription and lipid droplet
accumulation. Distinct from negative regulation of
SREBP-2bycholesterol, ourdata suggesta feedback
mechanism whereby maturation of nuclear, tran-
scriptionally active SREBP-1 is controlled by levels
of PC. Thus, nutritional or genetic conditions limiting
SAMe or PC production may activate SREBP-1,
contributing to human metabolic disorders.
INTRODUCTION
Disorders ofmetabolism, such as obesity, insulin resistance, and
nonalcoholic fatty liver disease (NAFLD), are associated with
metabolic syndrome and represent risk factors for more serious
diseases such as type II diabetes and cardiovascular dis-
ease. However, molecular mechanisms causing dysfunction in
these complex diseases remain unclear. The sterol regulatory840 Cell 147, 840–852, November 11, 2011 ª2011 Elsevier Inc.element-binding protein family (SREBP-1a, -1c, SREBP-2)
respond to nutrient levels and regulate transcription of genes
required for many aspects of lipid metabolism (Osborne and
Espenshade, 2009). SREBP-2 preferentially controls expression
of many cholesterogenic genes, whereas SREBP-1 isoforms
primarily regulate fatty acid, phospholipid, and triacylglycerol
(TAG) biosynthesis genes. In accordwith distinct gene regulatory
functions, activities of the isoforms appear to be controlled by
different regulatory cues. The cholesterol-mediated negative
feedback regulation of SREBP-2 is particularly well understood
(Brown and Goldstein, 1997). SREBP-2 is produced as an inac-
tive precursor stored with the cholesterol-sensing INSIG/SCAP
chaperone complex in the endoplasmic reticulum (ER). Deple-
tion of cholesterol promotes release from INSIG and SCAP-
mediated transit of SREBP-2 to theGolgi, followed by proteolytic
maturation and nuclear translocation of the transcriptionally
active portion to stimulate cholesterogenic gene expression.
SREBP-1a and -1c are produced through alternative promoter
usage and splicing of the SREBF1 gene (Horton et al., 2002).
Although SREBP-1 isoforms are also synthesized as ER-
targeted precursors, SREBP-1c does not appear to be primarily
controlled by cholesterol but rather responds to insulin signaling,
oxysterols, and feeding cues (Browning and Horton, 2004). In
Drosophila, palmitate and phosphatidylethanolamine may block
processing of the fly SREBP-1 ortholog dSREBP (Dobrosot-
skaya et al., 2002; Seegmiller et al., 2002) or affect expression
of dSREBP target genes in the heart (Lim et al., 2011). How-
ever, specific mechanisms linking metabolites from SREBP-1-
dependent transcriptional pathways to its maturation as a tran-
scription factor remain unclear.
Invertebrate systems such as Caenorhabditis elegans are
particularly attractive for determining links between genetics,
diet, andmetabolism. TheC. elegans intestine has both digestive
and endocrine functions and may model aspects of both hepatic
and adipose lipogenesis (Ashrafi et al., 2003). Importantly, the
single ortholog of SREBP in C. elegans, SBP-1, appears highly
conserved, regulating lipid storage similarly to mammalian
SREBP-1 (Horton et al., 2002; McKay et al., 2003). For example,
both mammalian SREBP-1 and SBP-1 activate stearoyl-CoA
desaturase genes (SCD and fat-6/fat-7, respectively), requiring
the ARC105/MED15/MDT-15 subunit of the Mediator transcrip-
tional coactivator (Yang et al., 2006). We also recently found that
both C. elegans SBP-1 and mammalian SREBP can be downre-
gulated by the NAD+-dependent sirtuin SIR-2.1/SIRT1 during
fasting (Walker et al., 2010). Thus, the C. elegans system is a
powerful tool to elucidate conserved gene regulatory mecha-
nisms by SREBP orthologs.
EmployingC. elegans andmammalianmodels, wehave uncov-
ered a conserved set of SBP-1/SREBP-1 target genes in the
one-carbon cycle (1CC), a pathway involving folate-methionine
metabolism and manufacture of the predominant methyl donor,
S-adenosylmethionine (SAMe). Because SAMe is required for
the methylation-dependent synthesis of phosphatidylcholine
(PC), a key membrane component, regulation of the 1CC by
SBP-1/SREBP-1 is consistent with its function in maintaining
phospholipid homeostasis (Hagen et al., 2010). Decreased levels
ofSAMeorPChavebeen linked tomultiplemodelsof hepatostea-
tosis in rodents and humans; however, mechanisms underlying
the strongly elevated lipogenesis have been unclear (Mato et al.,
2008; Vance et al., 2007; Vance and Vance, 2004; Zeisel, 2008).
Our observations indicate that an important regulatory mecha-
nism for SREBP-1 activation may operate when methylation
capacity or PC biogenesis is diminished and suggest that this
pathwaymaycontribute to lipidaccumulation in fatty liverdisease.
RESULTS
SREBPs Regulate 1CC Genes in C. elegans
and in Mammalian Cells
The SREBP family of transcription factors regulates genes
involved in biosynthesis and trafficking of cholesterol and other
lipids in mammals (Osborne and Espenshade, 2009). Employing
the nematodeC. elegans to elucidate conserved functions asso-
ciated with SREBP regulation in metazoans, we have carried out
genome-wide gene expression analysis on worms depleted of
the single SREBP ortholog SBP-1. As expected, the DNAmicro-
array studies showed that expression of many genes important
for fatty acid, TAG, and phospholipid production is dependent
on SBP-1 (Figure 1A and Figure S1A available online). Intrigu-
ingly, our analysis also found enrichment of genes predicted to
function in the one-carbon cycle (1CC) (Figures 1A–1C). The
1CC coordinates folate and methionine metabolism with pro-
duction of the methyl donor S-adenosylmethionine (SAMe)
(Mato and Lu, 2005). SAMe is critical for most cellular methyla-
tion reactions, including methylation-dependent synthesis of
a large number of cellular metabolites and phospholipids (Mato
et al., 2008). Because of the central importance of the 1CC to
metabolic homeostasis, we examined regulation of the 1CC by
SBP-1/SREBP in more detail. Analysis of individual 1CC genes
identified in DNA microarray studies, as well as closely related
genes, by quantitative RT-PCR (qRT-PCR) after sbp-1 RNAi
confirmed that a broad array of 1CC genes depend on SBP-1
for full expression (Figure 1C).Because 1CC genes had not been identified in previous
searches for mammalian SREBP target genes, we also exam-
ined their regulation in human cells. We found that overexpres-
sion of SREBP-1a in human embryonic kidney 293T cells
resulted in upregulation of multiple 1CC genes (Figure 1D).
Several of these, such as CTH and MAT1A, are orthologs of
genes identified in our C. elegans studies, whereas others, such
as CBS, appeared specific to regulation in mammalian cells.
We also found that expression ofMAT1A specifically depended
onSREBPs in human cells, whereasMAT2A did not (Figure S1B).
This suggests that SREBP regulation of 1CC genes is conserved
among metazoans and that metabolic flux through this pathway
may be controlled by SREBP orthologs.
Increased SBP-1-Dependent Lipogenesis and Gene
Expression after sams-1 Depletion in C. elegans
To better understand the link between methyl donor homeo-
stasis and regulation of these genes by SBP-1, we examined
phenotypes of nematodes depleted for the SAMe synthase-
encoding gene sams-1. The sams-1 gene was initially identified
in an RNAi screen for extended C. elegans life span (Hansen
et al., 1995). Surprisingly, we find that nematodes depleted or
mutated for sams-1 (sams-1(RNAi) and sams-1(lof), respectively)
also exhibit large refractile droplets within the intestine and body
cavity that stained with Sudan Black (Figures 2A–2C), suggest-
ing that lipid accumulation was increased. Accordingly, we
found that TAGs in sams-1(RNAi) nematodes were signifi-
cantly elevated when compared to controls (Table 1). Although
C. elegans harbor four additional sams genes, RNAi of sams-1
resulted in an approximately 65% decrease in SAMe levels,
with similar decreases in S-adenosylhomocysteine (SAH), the
product of SAMe-dependent methyltransferase reactions (Fig-
ure 2D). This suggests that sams-1 is required for the majority
of global SAMe production in C. elegans under normal growth
conditions. The lipid accumulation seen after sams-1 RNAi led
us to hypothesize that low methylation capacity may feedback
activate SBP-1 and promote increased lipogenesis, akin to
the classical feedback activation of mammalian SREBP-2 in
response to low cholesterol.
To determine whether decreased methylation capacity could
affect nuclear SBP-1 levels and promote elevated lipogenesis,
we examined cellular localization of a GFP::SBP-1 fusion protein
and SBP-1-dependent transcription of lipogenic genes in sams-
1(RNAi) nematodes. Indeed, GFP::SBP-1 showed increased
nuclear accumulation after sams-1 RNAi (Figure 2E), suggesting
that levels of transcriptionally active SBP-1 are increased. Con-
comitantly, expression of multiple SBP-1-dependent genes,
including the palmitoyl-CoA desaturase fat-5 and the stearoyl-
CoA desaturases fat-6 and fat-7, were increased in both sams-
1(RNAi) and sams-1(lof) animals (Figures 2F and S2A). Similar
levels of sbp-1 mRNA were present in control, sams-1(lof), and
sams-1(RNAi) nematodes, showing that regulation of SBP-1 in
response to SAMe depletion is likely posttranscriptional (Fig-
ure S2A; data not shown). To determine whether SBP-1 was
necessary for increased lipogenic gene expression after sams-1
RNAi, we examined sams-1 knockdown phenotypes in nema-
todes expressing a hypomorphic sbp-1 allele (sbp-1(ep79)). Ele-
vated expression of fat-5, fat-6, and fat-7, or the characteristicCell 147, 840–852, November 11, 2011 ª2011 Elsevier Inc. 841
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Figure 1. Coregulation of One-Carbon Cycle and Fatty Acid Biosynthesis Genes by SBP-1/SREBP-1
(A) Unbiased hierarchical clustering of genes more than 2-fold downregulated in sbp-1(RNAi) nematodes and with metabolic regulation KEGG terms shows that
one-carbon cycle (1CC) genes are decreased similarly to known SBP-1-responsive genes in lipid metabolism.
(B) Schematic diagram of the one-carbon cycle (1CC). SBP-1-dependent genes in C. elegans are shown in green; genes responsive to mammalian SREBP-1 are
shown in red.
(C) Quantitative RT-PCR (qRT-PCR) from control or sbp-1(RNAi) nematodes reveals that multiple 1CC genes require SBP-1 for expression.
(D) qRT-PCR from 293T cells overexpressing SREBP-1a shows that expression of multiple 1CC genes increases with elevated SREBP-1 activity.
Error bars show SD. Statistical relevance (p value) shown by < 0.05, *; < 0.01, **; < 0.005, ***. See also Figure S1.lipid droplets, was not observed when both sams-1 and sbp-1
function were limited (Figures 2F and S2B), suggesting that
SBP-1 is essential for increased lipogenesis after sams-1
depletion.
Decreased Phosphatidylcholine Production in
C. elegans Is Linked to Elevated SBP-1-Dependent Gene
Expression and Lipogenesis after sams-1 RNAi
We next examined whether depletion of sams-1 caused specific
metabolic changes that might be linked to increases in SBP-1
activity. Intriguingly, methylation-dependent phosphatidylcho-
line (PC) biogenesis intermediates were altered in metabolomic842 Cell 147, 840–852, November 11, 2011 ª2011 Elsevier Inc.analysis of sams-1-depleted nematodes (Figures 3B and 3C).
PC is produced by two alternative pathways. It can be synthe-
sized either from choline (Kennedy pathway) or by methylation
of phosphatidylethanolamine (PE) by PEMT in mammals, or of
phosphoethanolamine by PMT-1 and PMT-2 orthologs in
C. elegans and plants (Figure 3A) (Brendza et al., 2007; Palavalli
et al., 2006; Vance and Vance, 2004). In accord with the critical
role of methylation for the production of PC, we found signifi-
cantly lower levels of phosphocholine, the product of the PMT-1
methyltransferase (Figure 3B), as well as dramatically decreased
PC levels, after sams-1 RNAi, whereas PE was not significantly
changed (Figure 3C). Thus, marked alterations in phospholipid
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Figure 2. In C. elegans, SBP-1-Dependent Lipogenesis and Gene Expression Are Increased after sams-1(RNAi)
(A) RNAi knockdown of sams-1 revealed large refractile droplets in the intestine and body cavity by Nomarski optics.
(B) Enlarged view of droplets by Nomarski optics. The first sets of intestinal cells are shown, and the position of the pharynx is marked with a yellow star.
(C) Staining with Sudan Black shows that droplets in sams-1(RNAi) nematodes contain lipids.
(D) SAMe and SAH levels are significantly decreased after sams-1(RNAi). Error bars represent SEM between triplicate independent experiments.
(E) Nuclear accumulation of a GFP::SBP-1 fusion protein is increased in sams-1(RNAi) intestinal cells.
(F) qRT-PCR comparing levels of fat-5 and fat-7 in wild-type or a hypomorphic sbp-1 allele (ep79) demonstrated that FA desaturase upregulation in sams-1(RNAi)
animals depends on sbp-1.
Error bars show SD. Statistical relevance (p value) shown by < 0.05, *; < 0.01, **, < 0.005, ***. See also Figure S2.metabolism occur along with increased lipogenesis in sams-
1(RNAi) nematodes. Similar to our observation in sams-1-
deficient nematodes, accumulation of large lipid droplets has
been associated with low PC levels or changes in PC/PE ratios
in Drosophila and mammalian models (Guo et al., 2008; Jacobs
et al., 2008; Li et al., 2006). We therefore wished to determine
whether this increased lipid droplet formation might be linked
mechanistically to increased SBP-1/SREBP-1 activity.Table 1. Increased Triacylglycerols in sams-1, pcyt-1, or
cept-1(RNAi) Nematodes
%TAG SEM p value
Control 42.8 2.6
sams-1(RNAi) 64.5 4.1 0.0024
pcyt-1(RNAi) 51.4 1.6 0.0401
cept-1(RNAi) 50.8 1.6 0.0801
Quantitative analysis demonstrates increased storage of neutral lipids
after RNAi knockdown of genes necessary for PC production in nema-
todes when comparing percent triacylglycerol (TAG) to total lipids. SEM
is standard error of the mean.Production of PC from either phosphoethanolamine or PE
requires three sequential SAMe-dependent methylation steps;
however, PC synthesis from choline by the Kennedy pathway
is methylation independent (Vance and Vance, 2004). To deter-
mine whether rescuing PC production would reverse SBP-1-
dependent lipogenic events in sams-1(RNAi) nematodes, we
provided excess dietary choline. Strikingly, dietary choline sup-
plementation completely rescued accumulation of lipid drop-
lets and corrected overexpression of the SBP-1 transcriptional
targets fat-5, fat-6, and fat-7 in sams-1(RNAi) worms (Figures
S3A and S3B; data not shown). These results support our
hypothesis that decreased levels of PC in sams-1(RNAi) worms
may be directly linked to the increased SBP-1-dependent
lipogenesis.
Defective PC Production Results in Increased SBP-1-
Dependent Gene Expression and Lipogenesis in
C. elegans
Although decreasedmethylation capacity prevents adequate PC
synthesis, lowering levels of SAMe could also affect a broad
array of methyltransferases. We next wished to address theCell 147, 840–852, November 11, 2011 ª2011 Elsevier Inc. 843
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Figure 3. Increased Lipogenesis and SBP-1-Dependent Gene Expression after sams-1 RNAi in C. elegans Are Linked to Limited Phospha-
tidylcholine Production
(A) Schematic diagram of links between methyl production and phospholipid biosynthesis in nematodes. Enzymes whose functions are disrupted by RNAi in
subsequent panels are shown in blue boxes.
(B) Analysis of metabolites in sams-1(RNAi) nematodes shows that PC precursors downstream of methylation steps are decreased (phosphocholine), whereas
metabolites upstream (choline, ethanolamine, phosphoethanolamine) are unchanged or slightly increased. Error bars represent SEM between quadruplicate
independent experiments.
(C) Quantitative analysis shows that PC levels are diminished after sams-1(RNAi). Error bars represent SEM between quadruplicate independent experiments.
(D) GFP::SBP-1 accumulates in intestinal nuclei after pcyt-1(RNAi).
(E) Quantitative measurement of pfat-7::GFP intensity in C. elegans populations by a COPAS biosorter shows that RNAi knockdown of PC biosynthesis genes
downstream of methylation steps activate this SBP-1-dependent reporter at similar levels to sams-1 RNAi.
(F and G) Blocking methylation-dependent PC production by interference with PMT-1 produces similar phenotypes to sams-1(RNAi), such as increased lipid
droplet formation (F) and overexpression of SBP-1 transcriptional targets, fat-5 and fat-7 (G).
Error bars show SD; statistical relevance (p value) shown by < 0.05, *; < 0.01, **, < 0.005, ***. See also Figure S3 and Table S1.question of whether limiting PC levels are specifically associated
with SBP-1-dependent lipogenesis and lipid droplet formation in
C. elegans. Indeed, RNAi knockdown of pcyt-1 or cept-1, encod-
ing the final enzymes in the PC biosynthesis pathway (Figure 3A),
resulted in decreased PC levels, elevated nuclear localization of
GFP::SBP-1, and increased stored lipids, similar to what we
observed in sams-1(RNAi) nematodes (Figure 3D, Table 1, Table
S1, and data not shown). Furthermore, in an independent, unbi-
ased screen (V.R. and A.M.N., unpublished data), we found that
RNAi of genes involved in SAMe production or genes encoding
enzymes acting downstream of the methylation step in PC844 Cell 147, 840–852, November 11, 2011 ª2011 Elsevier Inc.biogenesis resulted in strong upregulation of a GFP reporter
fused to the promoter of the SBP-1 target gene fat-7 (pfat-
7::GFP) (Figure 3E). By contrast, RNAi of cka-1, encoding a
choline kinase upstream of the methylation-dependent PC
synthesis step, did not increase pfat-7::GFP expression (Fig-
ure 3E). We also examined lipid accumulation and expression
of SBP-1 target genes after knockdown of pmt-1, encoding the
PMT-1 phosphoethanolamine methyltransferase, a key con-
sumer of SAMe during PC production in C. elegans. Reduction
of pmt-1 expression causes a late larval arrest and defects
in PC production that can be rescued by dietary choline
supplementation (Brendza et al., 2007). We also found that
pmt-1 knockdown increased lipid droplet formation and caused
amarked elevation in expression of the SBP-1-responsive genes
fat-5 and fat-7 (Figures 3F and 3G). Although limitation of SAMe
production could cause pleiotropic phenotypes by reducing
activity of various distinct methyltransferases, the similar effects
of sams-1 or pmt-1 depletion on SBP-1-dependent gene expres-
sion and lipogenesis suggest that reduced production of PC is
directly affecting SBP-1 activity.
Activation of ER Stress Response in sams-1(RNAi)
Animals Is Not Linked to Elevated SBP-1-Dependent
Lipogenic Gene Expression
Because the decrease in PC levels tightly correlates with in-
creased SBP-1 activity, we hypothesized that lowered PC in in-
tracellular membranes could alter proteolytic processing and
maturation of SREBP-1 orthologs. ER stress may be sufficient
to initiate SREBP processing in mammals, independent of the
cholesterol feedback cycle (Ferre´ and Foufelle, 2010). There-
fore, we asked whether sams-1 depletion could promote ER
stress responses and whether such activation would be suffi-
cient to upregulate SBP-1-dependent gene expression. In
C. elegans, the BiP/GRP78 ortholog hsp-4 is induced by ER
stressors such as the glycosylation inhibitor tunicamycin and
depends on the activity of the ER stress effector XBP-1 (Calfon
et al., 2002). RNAi of sams-1 in a hsp-4::GFP reporter line
shows a strong xbp-1-dependent increase in GFP expression
(Figure S3C), suggesting that ER stress responses are robustly
activated in these animals. To determine whether ER stress
response was functionally important for the elevated SBP-1
activity observed after loss of sams-1, we knocked down the
ER stress effectors atf-6 or ire-1 (Shen et al., 2005) in sams-
1(lof) nematodes and found that SBP-1 target gene upregula-
tion and lipid droplet accumulation were not altered (Fig-
ure S3D; data not shown). Next we asked whether cellular
responses to ER stress could activate SBP-1 in wild-type
animals and found that SBP-1 target gene expression was
not affected by doses of tunicamycin causing mild or moderate
levels of lethality in control cultures (Figure S3E; data not
shown). Although our results point to a significant activation of
ER stress responses when sams-1 is depleted, ER stress does
not appear to cause increased SBP-1-dependent gene expres-
sion and lipogenesis.
Increase in Mammalian SREBP-1 Nuclear Localization
and Lipid Droplet Size after Blocking PC Biogenesis
in Human Hepatoma Cells
Our C. elegans results suggest that SBP-1 activity increases in
sams-1(RNAi) nematodes as methylation capacity is diminished,
and that mechanisms underlying this phenomenon are directly
related to decreased PC levels. In order to determine whether
mammalian SREBP-1 might also be regulated by PC deple-
tion, we used short-interfering (si) RNA technology to inhibit ex-
pression of genes necessary for PC production in human cells.
As in invertebrates, PC production in mammals may proceed
through methylation-dependent or -independent pathways,
although in mammals PE is methylated to generate PC (Fig-
ure 4A) (Vance and Vance, 2004). We found that blocking PCproduction through siRNA-mediated depletion of enzymes in
the methylation-dependent steps (MAT1A, PEMT) or enzymes
in the methylation-independent CDP-choline pathway (CTa,
CEPT) in human HepG2 hepatoma cells resulted in increased
accumulation of large lipid droplets, akin to our observations in
C. elegans (Figures 4B, 4D, 4F, S4E, data not shown). These
data are in accord with the development of fatty liver in Mat1a-
(Lu et al., 2001), Cta-, and Pemt-deficient mice on a high-fat
diet (Jacobs et al., 2008, 2010; Watkins et al., 2003) and with
accumulation of lipid droplets in cell culture models that limit
PC production (Guo et al., 2008; Jacobs et al., 2008; Testerink
et al., 2009). Our results reveal that along with increases in
lipid droplet size, HepG2 cells depleted of CTa, CEPT, MAT1A,
orPEMT showed SREBP-1 concentrated in the nucleus in immu-
nofluorescence assays (Figures 4C, 4E, S4B, and S4C), whereas
controls exhibited stronger staining in the cytoplasm, where the
inactive SREBP-1 precursor is stored. Furthermore, qRT-PCR of
CTa knockdown cells showed increased expression of SREBP-1
transcriptional targets SCD1 and MAT1A but no increases in
the expression of SREBF1 gene encoding the SREBP-1 protein
(Figure 4F), suggesting that elevation of SREBP-1 activity is likely
posttranscriptional. As in our C. elegans studies, these experi-
ments suggest that limitation of PC biosynthesis in mammalian
cells promotes elevated levels of nuclear SREBP-1, resulting
in increased SREBP-1-dependent gene expression, and in ele-
vated lipogenesis and lipid droplet formation.
In contrast with potent effects of PC limitation on SREBP-1
nuclear accumulation, nuclear levels of SREBP-2, which regu-
lates genes for cholesterol biosynthesis (Osborne and Espen-
shade, 2009), were already high in control cells and did not
increase when PC synthesis was blocked by siRNA of CTa,
CEPT,MAT1A, or PEMT (Figures 4G and S4D; data not shown).
Because strong nuclear accumulation of SREBP-2 is likely due
to low levels of cholesterol in our culture conditions, which could
mask additional effects from decreased PC, we also compared
SREBP-1 and SREBP-2 nuclear accumulation in the presence
of cholesterol. We found that SREBP-1 was preferentially nu-
clear in CTa and CEPT knockdown cells regardless of choles-
terol levels (Figures 4E, S4B, and S4C). However, nuclear levels
of SREBP-2 were high in low cholesterol and then decreased
when cholesterol was added, whether in control, CTa, or CEPT
knockdown cells (Figures 4G and S4D). This suggests that under
these culture conditions, blocking PC synthesis has a greater
effect on SREBP-1 nuclear accumulation, gene expression,
and lipogenesis, and that SREBP-2 responds preferentially to
cholesterol levels.
Decreased PC Biosynthesis in Murine Liver Promotes
SREBP-1 Proteolytic Maturation and Target Gene
Expression
To determine whether inhibition of PC biosynthesis in a mamma-
lian in vivo model also altered SREBP-1 processing and target
gene expression, we examined livers from mice deficient in PC
biosynthesis due to a liver-specific deletion in Cta, encoding
the rate-limiting enzyme in PC biosynthesis from choline (Vance
and Vance, 2004) and the ortholog to C. elegans pcyt-1. Livers
from Cta/ mice on a high-fat diet exhibit decreased PC and
increased TAG compared to controls but have normalCell 147, 840–852, November 11, 2011 ª2011 Elsevier Inc. 845
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Figure 4. Increase in Lipid Droplet Formation and SREBP-1a Nuclear Localization in Human Hepatoma Cells in Response to SAMe/PC
Depletion
(A) Schematic diagram of links between mammalian methyl production and phospholipid biosynthesis. Enzymes whose functions are disrupted by siRNA in
subsequent panels are shown in blue boxes.
(B–E) siRNA knockdown of PEMT, MAT1A (B), or CTa (D) causes increased accumulation of large lipid droplets by Oil Red O staining in HepG2 cells in lipid-
depleted serum. Immunostaining with an antibody against SREBP-1a shows increased nuclear accumulation after PEMT, MAT1A (C), or CTa (E) knockdown.
Cells were costained with antibodies recognizing the Golgi marker Giantin. Yellow lines show outline of cells.
(F) Analysis of gene expression in CTa knockdown HepG2 cells by qRT-PCR shows increases in SREBP-1-dependent genes such as SCD1 and MAT1A. Error
bars show SD. Statistical relevance (p value) is shown by <0.05, *; <0.01, **, <0.005, ***.
(G) Antibodies directed against SREBP-2 were used to stain HepG2 cells in lipid-depleted serum in the presence or absence of 10 mg/ml cholesterol in control or
CTa siRNA-treated cells.
See also Figure S4.cholesterol levels (Jacobs et al., 2004). To determine whether
SREBP function was altered, we examined SREBP-1 and
SREBP-2 in extracts from Cta/ livers by immunoblotting and
found higher levels of mature, processed SREBP-1 (Figures 5A
and 5B), suggesting that lowering PC is sufficient to affect
mammalian SREBP-1a/c proteolytic maturation. In accord with
our findings in C. elegans, expression of the D9 fatty acid desa-
turase and key lipogenic SREBP-1 target gene Scd1 (ortholo-
gous to fat-6 and fat-7) was increased in livers from Cta/
mice (Figure 5C). Previous studies of Cta/ mice did not
uncover changes in Scd1 expression, probably because of the
use of fasted mice (Jacobs et al., 2004), a condition known to846 Cell 147, 840–852, November 11, 2011 ª2011 Elsevier Inc.strongly inhibit SREBP target gene expression (Horton et al.,
1998; Walker et al., 2010). As previously reported (Jacobs
et al., 2005), expression of the sams-1 orthologMat1a is also up-
regulated in these livers. However, we found that levels of mature
SREBP-2 and expression of SREBP-2 target genes were not
increased in Cta/ livers, and that there were no increases in
the expression of the Srebf1a/c and Srebf2 genes themselves
(Figures 5C–5E). This in vivo study suggests that, as in our cell
culture studies, SREBP-2 activity may not be significantly
affected in response to altered PC levels, whereas processed,
mature SREBP-1 is increased, along with SREBP-1-dependent
transcription and concomitant lipogenesis.
A B C
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Figure 5. Increase in SREBP-1 Processing and Target Gene Expression in Cta Knockout Mouse Livers
(A) Immunoblotting of extracts frommicewith a liver-specific knockout ofCta (Jacobs et al., 2004) limiting theCDP-choline pathway shows increasedSREBP-1a/c
processing (Jacobs et al., 2004). Fl is full-length SREBP-1a/c precursor; I, intermediate form; M, mature, transcriptionally active form.
(B) Analysis of the immunoblot by densitometry shows increases in proteolytic products of SREBP-1 in livers from Cta knockout mice. Error bars show SD.
Statistical relevance (p value < 0.01) is shown by **.
(C) Analysis of gene expression by qRT-PCR from Cta knockout mice shows increased expression of Scd1, an SREBP-1 target, as well as Mat1a, ortholog of
sams-1. Bars represent individual mice; error bars show SD; statistical relevance (p value < 0.01) shown by (**).
(D and E) Analysis of gene expression by qRT-PCR from the liver-specific Cta knockout mice (Jacobs et al., 2004) shows no statistically significant changes in
levels of mature, processed SREBP-2 (D) or target gene expression (E). Bars represent individual mice; error bars show SD; statistical relevance (p value < 0.01)
shown by (**).Inhibition of PC Biosynthesis Affects Localization of
SREBP-Activating Proteases and Parallels Inactivation
of ARF-GTPases Regulating COPI Golgi-ER Retrograde
Transport
Our results indicate that lipogenic SREBPs (SBP-1/SREBP-1)
exhibit increased activity whenPC synthesis is limited. This regu-
lation occurs in the presence of cholesterol, suggesting that it
represents an independent mechanism to regulate SREBP-1.
Therefore, we examined the dependence of this regulatory cir-
cuit on SCAP, the cholesterol-binding chaperone essential for
the classical feedback pathway controlling SREBP-2 processing
and maturation (Brown and Goldstein, 1997). RNAi-mediated
depletion of Cta in SRD13A cells, in which SCAP is mutated
and inactivated (Hua et al., 1996), resulted in robust nuclear
accumulation of SREBP-1 (Figures 6A and S5A), suggesting
that the mechanism activating SREBP-1 in response to PC
depletion is indeed distinct from the classical pathway involving
SCAP-dependent transfer of SREBPs from the ER to the Golgi
when cholesterol is limiting.
Because PC is a major membrane component, and SREBP-1
activation occurs within the confines of the ER and Golgimembranes, we hypothesized that changes in these mem-
branes could lead to increased SREBP-1 activity. The balance
of PC/PE ratio affects membrane fluidity and curvature, and
depletion of PC can alter protein trafficking and lipid accumula-
tion (Hagen et al., 2010; Testerink et al., 2009). The antibiotic
brefeldin A (BFA) inactivates the ARF-GTPase cycle critical
for regulation of COPI or retrograde protein transport from
the Golgi apparatus to the ER (Donaldson and Lippincott-
Schwartz, 2000). BFA has also been reported to disrupt locali-
zation of the Golgi-resident SREBP-activating Site-1 and Site-2
proteases (S1P, S2P), causing ectopic proteolytic cleavage of
SREBP-2 in the ER (DeBose-Boyd et al., 1999). We asked
whether decreased PC levels could similarly affect S1P and
S2P localization to induce SREBP-1a processing and nuclear
accumulation. Interestingly, when CTa or CEPT were depleted
in HepG2 cells, S1P and S2P lost Golgi-specific localization
and appeared instead in a diffuse cytoplasmic pattern consis-
tent with KDEL ER-marker staining (Figures 6B, 6C, and
S5B–S5D; data not shown). Indeed, localization of two addi-
tional Golgi-specific proteins, Giantin and a-mannosidase,
was also disrupted (Figures 4C, 4E, 6B, 6C, S5B, and S5C),Cell 147, 840–852, November 11, 2011 ª2011 Elsevier Inc. 847
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Figure 6. Relocalization of SREBP-Activating Proteases in Mammalian Cells when PC Production Is Blocked
(A) SREBP-1 accumulates in the nucleus after CTa siRNA treatment in SRD13A cells, which lack a functional SCAP. Yellow lines show cell outlines.
(B and C) Coimmunostaining of HepG2 cells with the Golgi marker a-mannosidase and antibodies to S1P (B) or S2P (C) shows a strong shift away from an
organized Golgi structure and disorganization of SREBP-activating protease staining after CTa knockdown. Yellow arrow marks Golgi body in control cells.
(D and E) Interference with ARF-GTPase signaling by GBF1 siRNA treatment of HepG2 cells increases SREBP-1 nuclear accumulation (D) and disrupts Golgi-
specific partitioning of S1P (E).
(F) Schematic model for relocalization of SREBP-activating proteases, resulting in activation of SREBP-1 and transit to the nucleus upon decreased SAMe or PC
levels or blocks in ARF-GTPase cycles.
See also Figure S5.suggesting the Golgi may be broadly affected by changes in PC
levels.
Recent studies have found that the ARF-activating protein/
GEF GBF1 affects S2P localization in the unfolded protein re-
sponse (Citterio et al., 2008). To gain further insights into ER-
Golgi trafficking of SREBP-activating proteases, we used
siRNA to deplete GBF1 and found increases in SREBP-1 nu-
clear accumulation and redistribution of S1 and S2 proteases
to an ER-like pattern, similar to the effects of PC depletion
(Figures 6D, 6E, S5E, and S2F). ARF signaling may also be in-848 Cell 147, 840–852, November 11, 2011 ª2011 Elsevier Inc.hibited by increases in membrane curvature (Bigay et al.,
2003), which are predicted to occur when membrane PC levels
drop (Lev, 2006). Thus, SREBP-1 nuclear accumulation could
occur if PC levels drop and membrane curvature inhibits
ARF-GTPase signaling, allowing relocalization of S1P and
S2P to the ER and proteolytic activation of SREBP-1 (Fig-
ure 6F). Limitations in choline or methionine metabolism af-
fecting PC synthesis could activate SREBP-1 through this
mechanism, promoting the lipid accumulation in fatty liver
disease.
DISCUSSION
Regulation of SBP-1/SREBP-1 Activity by Phospholipids
Studies by a number of groups have revealed a complex regula-
tory relationshipbetweenSREBPsandphospholipids.SREBP-1a
has been implicated as a regulator of phospholipid biogenesis
genes in mammals (Hagen et al., 2010), and we have found that
multiple PC biosynthesis genes are dependent on SBP-1 in
C. elegans (Figures 1A, 1B, and S1A). In a Drosophila cell culture
model, Dobrosotskaya et al. showed that palmitate and precur-
sors to PE are potent inhibitors of dSREBP processing (Dobro-
sotskaya et al., 2002). However, genes or metabolites leading
directly to PC biosynthesis were not examined. The differences
in our studies may reflect a distinct SREBP-regulatory circuit in
Drosophila, or perhaps that specific combinations of mem-
brane phospholipids may differently affect SREBP processing.
Nevertheless, a recent study showed that low PE levels in the
Drosophilaheart affect cardiac lipidaccumulation andexpression
of dSREBP target genes (Lim et al., 2011), strengthening links
between phospholipids and regulation of SREBP-1 orthologs.
Activation of SBP-1/SREBP-1 in Response to Low PC:
An Alternative to Cholesterol-Based Regulatory
Mechanisms
Activation of SREBPs involves the ER, where full-length SREBP
precursors are stored, and the Golgi, housing the SREBP-acti-
vating proteases S1P and S2P. Our data suggest that changes
in PC levels may alter membrane function leading to SREBP-1
activation. ER stress has previously been linked to SREBP acti-
vation (Hotamisligil, 2010) and recently to PC/PE ratios in leptin-
deficient, ob/ob mice (Fu et al., 2011). The ER-stress inducer
ATF-6 is regulated similarly to SREBPs (Ye et al., 2000), thus
ATF-6 could also be activated if S1P and S2P lose Golgi-specific
localization. However, our data suggest that ER stress re-
sponsesmay occur in parallel to SBP-1 activation because stim-
ulating the ER stress response was not sufficient to increase
SBP-1 activity (Figure S3E; data not shown). Therefore, we con-
clude that SBP-1 activation mechanisms in response to low PC
are likely independent of ER stress responses.
Elegant studies have shown that Golgi and ER separation is
crucial for SREBP regulation (Bartz et al., 2008; DeBose-Boyd
et al., 1999). In these studies, cells were treated with BFA, which
disrupts Golgi function by inhibiting ARF-GTPase cycles essen-
tial for protein sorting in COPI-dependent Golgi-to-ER retro-
grade transport (Mansour et al., 1999; Peyroche et al., 1999).
When cells are treated with BFA, S1 and S2 proteases collect
in the ER (Bartz et al., 2008; DeBose-Boyd et al., 1999),
activating SREBP-2. We have found that availability of methyl
donors or PC also alters localization of S1P and S2P (Figures
6B, 6C, S5B, and S5C) and increases in mature, nuclear
SREBP-1 (Figures 4C, 4E, S4B, and S4C). Intriguingly, lowering
membrane PC content and BFA treatment are both predicted to
inhibit ARF-GTPase cycles, although by different mechanisms.
BFA binds ARF-GDP, preventing formation of active GTP-bound
ARF (Donaldson and Lippincott-Schwartz, 2000). Membranes
with low PC/PE ratios exhibit increased curvature (Lev, 2006),
activating the ARF-GTPase repressor ARF-GAP (Bigay et al.,
2003). In support of this model, S2P moved from Golgi to theER when an ARF-activating factor, GBF1, was depleted (Citterio
et al., 2008). Importantly, similar to depletion of PC synthesis
enzymes (Figure 6D), we have found that depletion of GBF1
also causes SREBP-1 nuclear accumulation, showing that alter-
ations in ARF-GTPase cycles are sufficient to activate SREBP-1.
Taken together, these data suggest a simple mechanism for
increasing SREBP-1 processing when membrane PC is limiting;
increased curvature of the membrane may affect ARF signaling,
deregulate COPI transport, and shift the distribution of S1P or
S2P toward the ER, where they cleave and activate SREBP-1.
Intriguingly, we found that SREBP-2 was not affected by this
PC-based activationmechanism (Figures 4G and S4D), although
it is activated by BFA (DeBose-Boyd et al., 1999), suggesting the
possibility that SREBP-1 and SREBP-2 precursors may respond
differently to these cues.
Phosphatidylcholine, 1CC Metabolism, and Links
to Hepatic Lipogenesis
Lipid accumulation in the liver (hepatosteatosis) is an early step
in nonalcoholic fatty liver disease (NAFLD) (Browning and Hor-
ton, 2004) and appears to predispose to subsequent, more
severe pathological changes (Browning and Horton, 2004; Li
et al., 2006). Although hepatic lipid accumulation may be driven
by SREBP-1c in response to high insulin levels, as seen in meta-
bolic syndrome models (Browning and Horton, 2004; Ferre´ and
Foufelle, 2010), it may also occur when dietary or genetic lesions
alter 1C metabolism or SAMe production or decrease PC levels
(Larter and Yeh, 2008; Mato et al., 2008). PEMT polymorphisms,
and a reduced PC/PE ratio, have also been associated with
NAFLD in humans (Li et al., 2006; Song et al., 2005). When PC
biosynthesis is limited in mice, hepatosteatosis is not concur-
rent with insulin resistance (Cta/) (Jacobs et al., 2004), and
Pemt/mice in fact exhibit increased insulin sensitivity (Jacobs
et al., 2010), suggesting that the excess lipid production when
PC is limiting is not linked to SREBP-1c upregulation as a func-
tion of insulin resistance. Unlike insulin- or oxysterol-dependent
effects on SREBP-1c function (Osborne and Espenshade, 2009),
the PC-linked increases are not accompanied by upregulation
of the SREBF1 transcript. This indicates that lower levels of PC
resulting from diminished methylation capacity act by promoting
SREBP-1 processing.
Our data suggest that the increase in nuclear SREBP-1 levels
in response to limiting PCmay promote elevated lipogenesis and
contribute to steatosis in early stages of fatty liver diseases.
Indeed, increased hepatic lipids are associatedwith diverse con-
ditions such as intravenous (parenteral) feeding (Buchman et al.,
1995), cystic fibrosis-associated liver disease (Colombo et al.,
1998), or excess alcohol consumption (Kharbanda, 2009), in
which dietary availability, absorption, or metabolism of choline
and/or other 1CC metabolites could be affected. Choline sup-
plementation can reverse hepatic lipid accumulation associated
with total parenteral feeding (Buchman et al., 1995) and improve
abnormal 1CC metabolite plasma levels in cystic fibrosis
patients (Innis et al., 2007). Our results provide a mechanistic
rationale for further exploring choline and SAMe supplementa-
tion as treatments for fatty liver diseases in humans.
To conclude, we propose a model where SBP-1/SREBP-1 is
part of a conserved feedback loop responding to PC levels toCell 147, 840–852, November 11, 2011 ª2011 Elsevier Inc. 849
regulate expression of 1CC biogenesis genes and ensure
adequate SAMe levels for PC production. Activation of other
SBP-1/SREBP-1 targets in fatty acid biosynthesis pathways
may also occur concomitantly, driving TAG production when
PC levels are chronically low. Thus, abrogated PC feedback
could be amajor contributor to SREBP-1-dependent lipogenesis
when methyl group metabolism is compromised by diet or
genetics and predispose to hepatic lipid accumulation and fatty
liver disease.
EXPERIMENTAL PROCEDURES
The Supplemental Information includes Extended Experimental Procedures.
C. elegans strains, RNAi protocols, dietary rescue, and COPAS biosorting
procedures are presented. Also included are cell culture conditions and
antibodies.
C. elegans:Whole-Genome Analysis
Synchronized larvae from control and sbp-1 RNAi cultures were harvested
and RNA was isolated. cDNA was produced and hybridized to Affymetrix
C. elegans arrays. Responsive genes were defined as having a greater than
2-fold change.
C. elegans: Metabolite Analysis
Replicates of synchronized L4/young adult C. elegans cultures from control or
sams-1 RNAi treatment were harvested, frozen in liquid N2, and analyzed by
Metabolon. The unbiased global metabolic profiling platform utilized three
independent instrument platforms: ultrahigh performance liquid chromatog-
raphy/tandem mass spectrometry (UHPLC/MS/MS) optimized for basic spe-
cies, UHPLC/MS/MS optimized for acidic species, and gas chromatography/
mass spectrometry (GC/MS). The platform is described in detail in a previous
publication (Evans et al., 2009). Briefly, samples were homogenized in a fixed
ratio of water (sample amount/volume of water) then extracted using an auto-
mated MicroLab STAR system (Hamilton Company) in a fixed ratio (sample
amount/volume) of methanol containing recovery standards. The resulting
extract was split for analysis on the three platforms, and ion features were
matched against platform-specific compound chemical libraries. UHPLC/MS
utilized a Waters Acquity UPLC (Waters Corporation) coupled to an LTQ
mass spectrometer (Thermo-Fisher Scientific Inc.) equipped with an electro-
spray ionization source. Two separate UHPLC/MS injections were performed
for each sample: one optimized for positive ions and one for negative ions.
Derivatized samples for GC/MS were analyzed on a Thermo-Finnigan Trace
DSQ fast-scanning single-quadrupole MS operated at unit mass resolving
power. Chromatographic separation, followed by full scan mass spectra,
was preformed to record retention time, molecular weight (m/z), and MS/MS
of all detectable ions present in the samples. Metabolites were identified by
automated searching to compare ion features in experimental samples to
a reference library of chemical standard entries that included retention time,
molecular weight (m/z), preferred adducts, and in-source fragments, as well
as their associated MS/M spectra. This library match procedure allowed rapid
identification of metabolites in the experimental samples with high confidence.
Comparison of experimental samples to process blanks (water only) and
solvent blanks allowed automated removal of artifactual peaks.
Missing values for a given metabolite were assigned the observed minimum
detected value, based on the assumption that the missing values were below
the limits of detection. For the convenience of graphical visualization, the
raw area counts for each metabolite were rescaled by dividing each sample
value by themedian observed value (excluding imputed values) for the specific
metabolite. Statistical analysis was performed using ‘‘R’’ (http://cran.r-project.
org/), a freely available open-source software package. A log transformation
was applied to the observed relative concentrations for each biochemical
because the variance generally increased as a function of each biochemical’s
average response. Welch’s t tests, a variation of Student’s t test for samples
with unequal variances, were performed to compare data obtained between
experimental groups in the study. The false-positive rate associated with850 Cell 147, 840–852, November 11, 2011 ª2011 Elsevier Inc.multiple comparisons was calculated using the false discovery rate (FDR)
method of Storey and Tibshirani (2003); q values for all tests were provided
to the client.
C. elegans: Lipid Measurements
Lipids extraction, separation, and quantification (modified from Watts and
Browse, 2006) were as follows:Wormswere grown for 4 days starting from iso-
lated early embryos plated on NGM plates. Lipids were extracted from frozen
worm pellets with (10:10:1) chloroform/methanol/formic acid at 20 for at
least 12 hr. The extract was washed with 0.2 M H3PO4, 1 M KCl. Lipids were
recovered in the chloroform phase, dried under N2, and redissolved in chloro-
form containing 0.01%BHT. Individual lipidswere purified from the extracts by
one-dimensional thin layer chromatography. Neutral lipids were separated on
silica gel HL plates (Analtech) using 80:20:3 hexane/diethyl ether/acetic acid
solvent mixture. Polar lipids were separated using a 65:43:3:2.6 chloroform/
methanol/water/acetic acid solvent mixture. Separated lipids were visualized
using 0.05%primuline dissolved in 80% acetone, compared to authentic stan-
dards and scraped immediately for fatty-acid methyl ester derivatization. The
internal standard (15:0) was added prior to esterification. Fatty-acid methyl
esters were prepared with 2.5% methanolic H2SO4 for analysis by gas chro-
matography (Watts and Browse, 2002). The relative amounts of phosphatidyl-
choline, phosphatidylethanolamine, and triacylglycerols were determined
based on the relative amounts of fatty acids detected in each lipid fraction.
C. elegans: Dietary Rescue or Drug Treatment
For dietary rescue experiments in RNAi knockdown experiments, animals
were hatched onto RNAi or control plates. On the day animals reached the
L4 stage, they were washed off into S-basal media supplemented with RNAi
bacteria and varying amounts of choline in 6-well plates. Plates were placed
on rotators at 20C for 18 hr before harvesting.
Cell Culture and siRNA
For analysis of gene expression in HEK293T cells (cultured as in Walker et al.,
2010), SREBP-1a was transfected by Lipofectamine 2000 (Life Technologies),
and cells were harvested after 48 hr. For gene knockdown in HepG2 cells,
siRNA Smartpools (Thermo-Fisher Scientific) were transfected by Amaxa
Nucleofector (Lonza), and cells were placed in 1% lipid-depleted serum,
then harvested after 24 hr.
Immunohistochemistry or Staining with Lipid-Soluble Dyes
Antibody staining of SREBPs in cultured cells and C. elegans Sudan Black
stainingwere performed as inWalker et al. (2010). S1P and S2P antibody stain-
ing were performed as in Bartz et al. (2008). For Oil Red O staining, cells were
transfected with siRNA oligonucleotides by Amaxa Nucleofector and placed in
1% lipid-depleted serum. After 24 hr, cells were fixed, stained with Oil Red O
for 10min, and visualized.Microscopy for immunostaining andOil RedO stain-
ing was performed on an Olympus ix81. Montages of images deconvolved by
Nearest Neighbor algorithms were further processed by Adobe Photoshop.
Animal Handling and Liver Extract Preparation
Male liver-specific Cta knockout and control mice (12 weeks old) were given
free access to the high-fat diet (Bioserve, #F3282) for 3 days. Liver samples
were collected from fed animals and either processed for immunoblotting
with antibodies to SREBP or into Tri-reagent (Sigma) for RNA isolation. All
procedures were approved by the University of Alberta’s Institutional Animal
Care Committee in accordance with guidelines of the Canadian Council on
Animal Care.
mRNA Isolation and qPCR
mRNA was extracted by Tri-reagent (Sigma). cDNA was made from total RNA
with a Transcriptor cDNA synthesis kit (Roche). qPCR was run on a Roche 480
light cycler. Duplicate samples from at least three biologically independent
experiments were analyzed. Statistical significance was determined by calcu-
lating standard deviation (SD) and Student’s t test. For mRNA isolation from
mouse liver, after homogenization in Tri-reagent, RNA was further purified by
RNAeasy columns (QIAGEN) before proceeding to cDNA synthesis and
qPCR as above.
SUPPLEMENTAL INFORMATION
Supplemental information includes Extended Experimental Procedures, five
figures, and one table and can be found with this article online at doi:10.
1016/j.cell.2011.09.045.
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